Biocon Ltd (BIOCON) — Announcement | 21 September 2026

21 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Biocon's Pertuzumab biosimilar secures EMA CHMP approval recommendation

🔮 What's Next

European Commission will now proceed with final review and issue decision; SmPC to be available in all EU languages post-decision

Biocon announced that its biosimilar Pertuzumab received a positive EMA CHMP recommendation for treating HER2-positive breast cancer under the brand name Pebrilzo®, marking the first biosimilar approved under EMA's new clinical approach and positioning it for EU market entry pending final authorization.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BIOCON ✨ Ask AI About This

About Biocon Ltd (BIOCON)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹61,113.53 CrP/E: 146.5ROE: 1.4%ROCE: 2.9%Div Yield: 0.13%

View full BIOCON stock details →

📡 Get AI alerts when BIOCON files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BIOCON — Free

💡 Ask AI about this filing

"When will EMA finalize Pebrilzo® approval?""What revenue contribution does Pebrilzo® represent in Biocon's biosimilars portfolio?""How does this approval compare to competitors' biosimilar timelines?"

Ask AI Free →

📊 More BIOCON filings

Announcement — 25 September 2026Biocon announced that its Malaysian subsidiary obtained MHRA approval for a new insulin fill-finish ...
🔴 Corporate Action — 9 September 2026Biocon announced a final dividend of ₹0.50 per share for FY 2025-26, approved at the August 6, 2026 ...
🔴 Announcement — 8 September 2026Biocon announced a 10-year supply agreement for Pertuzumab in Brazil through a partnership with Bahi...
🔴 Announcement — 8 September 2026Biocon announced its upcoming investor meetings schedule, including a Sep 11 roadshow in Mumbai, to ...
🔴 Announcement — 31 August 2026Biocon announced its schedule of analyst and institutional investor meetings for September 4, 2026, ...

See all BIOCON filings →

🔥 Also filed on 21 September 2026

544900Complete Sports and Management India LimitedAnnouncement MCLOUDMagellanic Cloud LtdAnnouncement PATANJALIPatanjali Foods LtdAnnouncement PREMIERENEPremier Energies LtdAnnouncement 523373Mini Diamonds (India) LtdAnnouncement HTELHy-Tech Engineers LtdFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BIOCON files new disclosures

Track BIOCON filings, board meetings, and corporate actions. Free email alerts at 5 PM.